BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival

BACKGROUND: Around 50% of primary melanomas harbour BRAF mutations, but their prognostic impact has not been clear. Recently, a BRAF-V600E mutation-specific antibody has become available for immunohistochemistry. Here, we investigated for the first time the prognostic impact of BRAF-V600E protein ex...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Cancer
Prif Awduron: Hugdahl, Emilia, Kalvenes, May Britt, Puntervoll, Hanne E, Ladstein, Rita G, Akslen, Lars A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2016
Pynciau:
Molecular Diagnostics
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984864/
https://ncbi.nlm.nih.gov/pubmed/26924424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.44
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg